Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 17

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 2
Chunk 17
---
 Months Ended June 30,Change20252024Amount%(dollars in thousands)Revenue:Product revenue$8,903 $8,250 $653 7.9 %Service revenue5,564 3,979 1,585 39.8 %Total revenue14,467 12,229 2,238 18.3 %Costs and operating expenses:Cost of product revenue10,344 10,090 254 2.5 %Cost of service revenue3,444 3,851 (407)(10.6)%Research and development6,854 7,586 (732)(9.6)%Sales and marketing5,865 6,908 (1,043)(15.1)%General and administrative11,769 11,445 324 2.8 %Total costs and operating expenses38,276 39,880 (1,604)(4.0)%Loss from operations(23,809)(27,651)3,842 (13.9)%Other income (expense):Interest income, net817 1,821 (1,004)(55.1)%Other (expense) income, net(111)(52)(59)113.5 %Total other income (expense), net706 1,769 (1,063)(60.1)%Loss before income taxes(23,103)(25,882)2,779 (10.7)%Income tax expense18 18 — — %Net loss$(23,121)$(25,900)$2,779 (10.7)%

Revenue

Product revenue increased by $0.7 million, or 7.9%. The increase was driven primarily by a higher volume of consumables as well as an increase in the average selling price of our systems.  Higher system-related revenue, particularly from software sales, also contributed to the increase. The increase from these factors was partially offset by one fewer system placement during the six months ended June 30, 2025 compared to the same period in 2024. 

Service revenue increased by $1.6 million, or 39.8%. The increase in service revenue was primarily driven by increases in revenue related to validations and installations (including higher one-time services unrelated to new system 

40

sales) as well as higher service contract revenue as a result of an increase in the cumulative number of Growth Direct systems validated and under such contracts